Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5412)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2023 (publication date) through Jul 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wibawa IDN, Mariadi IK, Somayana G, Krisnawardani Kumbara CIY, Sindhughosa DA. Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management. World J Diabetes 2023; 14(5): 549-559 [PMID: 37273247 DOI: 10.4239/wjd.v14.i5.549] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i5/549.htm |
| Number | Citing Articles |
| 1 |
Marwin A. Farrugia, Enzo Pini, Albert Tran, Nicolas Chevalier, Rodolphe Anty, Philippe Gual. Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-025-00646-8
|